4//SEC Filing
Kline Ashley Hartmann 4
Accession 0001583648-25-000030
CIK 0001583648other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 9:15 PM ET
Size
7.7 KB
Accession
0001583648-25-000030
Insider Transaction Report
Form 4
Kline Ashley Hartmann
Chief Commercial Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2025-05-27+17,436→ 17,436 totalExercise: $22.94Exp: 2035-05-26→ Common Stock (17,436 underlying) - Award
Non-Qualified Stock Option (right to buy)
2025-05-27+111,496→ 111,496 totalExercise: $22.94Exp: 2035-05-26→ Common Stock (111,496 underlying)
Footnotes (1)
- [F1]The option vests 25% on May 27, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
Documents
Issuer
PALVELLA THERAPEUTICS, INC.
CIK 0001583648
Entity typeother
Related Parties
1- filerCIK 0002071433
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 9:15 PM ET
- Size
- 7.7 KB